Corvus Pharmaceuticals Inc (FRA:C17)
€ 8.11 -0.01 (-0.12%) Market Cap: 547.60 Mil Enterprise Value: 504.48 Mil PE Ratio: 0 PB Ratio: 10.74 GF Score: 22/100

Q3 2019 Corvus Pharmaceuticals Inc Earnings Call Transcript

Oct 29, 2019 / 08:30PM GMT
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Corvus Pharmaceuticals Third Quarter 2019 Update and Financial Results Webcast. Today's conference is being recorded. (Operator Instructions)

It is now my pleasure to turn the call over to [Zack Kubow] of [Pure Communications]. Please go ahead, sir.

Unidentified Participant

Thank you, operator, and good afternoon, everyone. Thanks for joining us for the Corvus Pharmaceuticals Third Quarter 2019 Business Update and Financial Results Conference Call. On the call to discuss the results and business highlights for the third quarter 2019 are Richard Miller, Chief Executive Officer; Leiv Lea, Chief Financial Officer; and Mehrdad Mobasher, Chief Medical Officer. Also joining the call are Corvus' senior scientist, Dr. Stephen Willingham, and Dr. Drew Hotson. The executive team will open the call with some prepared remarks followed by a question-and-answer period.

I would like to remind everyone that comments made by management today and answers to questions will include

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot